High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant | MicrobiomeTrials← Back to trialsNCT03719092
High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant
CompletedNAINTERVENTIONAL
Trial Details
Start: 2020-02-07Est. Completion: 2025-04-30
Enrollment target: 62 participants Locations- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Biphenotypic LeukemiaAcute Undifferentiated LeukemiaCLL (Chronic Lymphocytic Leukemia)Chronic Myeloid Leukemia (CML)MDS (Myelodysplastic Syndrome)Non-Hodgkin LymphomasHodgkins LymphomaCutaneous T Cell Lymphomas (CTCL)
The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marro…
Duarte, United StatesEst. completion Jul 14, 2026
Phase 2
Recruiting
Background:
\- GATA2 deficiency is a disease caused by mutations in the GATA2 gene. It can cause different types of leu…
Bethesda, United StatesEst. completion Dec 31, 2027
HIVHematologic Malignancies
Background:
People living with HIV(PLWH) are at a higher risk for cancers that may be curable with a bone marrow transp…
Bethesda, United StatesEst. completion Jul 30, 2027